华中科技

The medical isotope industry welcomes the big good news! The medium and long-term development plan for medical isotopes will be released, which will change the current situation of import dependence and reduce the cost of diagnosis and treatment of major diseases

On 14^th day, China is about to release a medium and long-term development plan for medical isotopes (2021-2035), Xinhua finance reporter said at the China Nuclear Energy Sustainable Development Forum in Beijing. Medical radioisotope is the raw material of radioisotope drugs, which plays a unique role in the early diagnosis of major diseases and the precise removal of tiny lesions.The release of the plan is of great significance for changing the current situation of heavy dependence on imported medical isotopes and reducing the cost of related diagnosis and treatment. Liu Yongde, chief engineer of the China Atomic Energy Authority, said that the China Atomic Energy Authority and the Ministry of Science and Technology, the Ministry of Public Security, the Ministry of Ecology and Environment, the Ministry of Transport, the National Health Commission, the National Medical Insurance Administration, and the Drug Administration will soon formally release the plan. It is the country's first special plan for a single area of nuclear technology application. Planning for the development of medical isotopes, the production, the radioactive drugs research and development, health policy, industrial layout, and other important aspects for the deployment, I believe that through the release of planning, strategy implementation in promoting health China at the same time, will further expand the use of nuclear technology in the medical field scale, open up new areas of nuclear technology to benefit human, and to create a favorable social environment for China's nuclear energy development. (Xinhua Finance reporter Ding Yawen and Anna)